BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16037652)

  • 1. [The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests].
    Sorrentino GC; Caffari B; Vanacore N; Maggini M; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):63-8. PubMed ID: 16037652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dementias: mostly clinico-neuropsychological or mostly psychometric diagnosis?].
    Spinnler H
    Ann Ist Super Sanita; 2005; 41(1):75-80. PubMed ID: 16037654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A; Padovani A; Trabucchi M
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):87-8. PubMed ID: 12497562
    [No Abstract]   [Full Text] [Related]  

  • 6. Navigating patients and caregivers through the course of Alzheimer's disease.
    Aupperle PM
    J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
    Smith B; Chur-Hansen A; Neale A; Symon J
    Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming stigma to seek help for Alzheimer's.
    Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):6-7. PubMed ID: 16921652
    [No Abstract]   [Full Text] [Related]  

  • 10. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 11. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P; Essner U; Forstl H
    Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management and therapy of Alzheimer's disease. Recommendations of a general practitioners' guideline].
    Vollmar HC; Wilm S
    MMW Fortschr Med; 2009 Jun; 151(24):36-40; quiz 41. PubMed ID: 19645200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 18. Latest approaches in Alzheimer's care.
    Nadler-Moodie M; Wilson MF
    RN; 1998 Jul; 61(7):42-5; quiz 46. PubMed ID: 9687816
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver characteristics are associated with neuropsychiatric symptoms of dementia.
    Sink KM; Covinsky KE; Barnes DE; Newcomer RJ; Yaffe K
    J Am Geriatr Soc; 2006 May; 54(5):796-803. PubMed ID: 16696746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.